Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCDT plus anticoagulation for acute iliofemoral DVT
NCT04411316Phase 4Withdrawn
- Sponsor
- University of Toledo Health Science Campus
- Start
- Dec 2019
- Primary completion
- Dec 2022
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of tissue-plasminogen activator in deep vein thrombosis (DVT), sponsored by University of Toledo Health Science Campus. Planned start Dec 2019; status: withdrawn.
02
Drugs
tissue-plasminogen activator
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT04411316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04411316.